Support Our Appeals to Fight Oesophageal Cancer
At Heartburn Cancer UK, we are dedicated to raising awareness, funding crucial research, and providing support for those affected by oesophageal cancer and Barrett’s oesophagus. Our appeals are designed to address specific needs and drive forward our mission to improve early diagnosis, treatment, and support for patients and their families.
Many people are unaware that persistent heartburn and acid reflux can be early signs of oesophageal cancer. Through targeted awareness initiatives, we aim to educate the public about these risks and encourage early medical consultation, which can significantly improve outcomes.
In addition, we are committed to providing support services for patients and their families. Dealing with a diagnosis of oesophageal cancer can be overwhelming, and having access to resources, support groups, and counseling can make a profound difference. Your donations help us maintain and expand these essential services, ensuring that no one has to face this journey alone.
Our appeals also support the development of educational materials for healthcare professionals, ensuring they have the latest information on best practices for diagnosing and treating oesophageal cancer. This, in turn, helps improve patient care and outcomes.
Your contributions to our appeals help us fund vital research projects aimed at understanding oesophageal cancer better, developing innovative diagnostic methods, and improving treatment options. By supporting our appeals, you are directly contributing to the advancement of medical knowledge and the creation of more effective, life-saving interventions.
The Burning Question
…Is it really just heartburn?
Did you know that persistent heartburn can be an early symptom of oesophageal cancer? Very few people are aware of this potentially life saving information. HCUK work to raise awareness, improve early diagnosis and save lives.
Early Diagnosis – Saving Lives
We are fundraising to establish a longer term early diagnostic service using our mobile units and capsule sponge test devices, like The Cytosponge™ and EndoSign®. This will support earlier diagnosis to improve outcomes and save lives.